Raymond J. Bergeron

Affiliations: 
University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Pharmaceutical Chemistry
Google:
"Raymond Bergeron"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bergeron RJ, Bharti N, McManis JS, et al. (2015) Metabolically programmed iron chelators. Bioorganic & Medicinal Chemistry. 23: 5954-71
Bergeron RJ, Wiegand J, McManis JS, et al. (2014) Desferrithiocin: a search for clinically effective iron chelators. Journal of Medicinal Chemistry. 57: 9259-91
Bergeron RJ, Wiegand J, Bharti N, et al. (2012) Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles. Journal of Medicinal Chemistry. 55: 7090-103
Bergeron RJ, Wiegand J, Bharti N, et al. (2011) Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. 24: 239-58
Bergeron RJ, Singh S, Bharti N, et al. (2010) Design, Synthesis, and Testing of Polyamine Vectored Iron Chelators. Synthesis. 2010: 3631-3636
Bergeron RJ, Bharti N, Wiegand J, et al. (2010) The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues. Journal of Medicinal Chemistry. 53: 2843-53
Bergeron RJ, Wiegand J, Singh S. (2009) Desferrithiocin analogue uranium decorporation agents. International Journal of Radiation Biology. 85: 348-61
Bergeron RJ, Wiegand J, McManis JS, et al. (2008) Desferrithiocin analogues and nephrotoxicity. Journal of Medicinal Chemistry. 51: 5993-6004
Bergeron RJ, Wiegand J, McManis JS, et al. (2008) Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues. Journal of Medicinal Chemistry. 51: 3913-23
Bergeron RJ, Wiegand J, Bharti N, et al. (2007) Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution. Journal of Medicinal Chemistry. 50: 3302-13
See more...